AI Article Synopsis
- Obesity is a global health problem, defined by a body mass index (BMI) of 30kg/m² or higher, and increases the risk of blood clots and their recurrence.
- * Obese individuals are frequently prescribed anticoagulant therapy to manage these risks, but there is limited research from randomized control trials on this topic.
- * This narrative review will explore the current guidelines and practices regarding anticoagulant use for preventing and treating venous thromboembolism (VTE) in obese patients.
Article Abstract
Obesity is an alarming worldwide public health issue and is defined as a body mass index (BMI) of 30kg/m or more. It is considered as a risk factor for first thrombotic event and is associated with a significant risk of recurrence. Consequently, obese patients are often treated by anticoagulant therapy but data from randomised control trial are scarce. We will review in this narrative review the state of the art of the prescription of anticoagulant for the prevention and treatment of venous thromboembolism (VTE) in obese patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jdmv.2024.08.001 | DOI Listing |
Publication Analysis
Top Keywords
obese patients
12
venous thromboembolism
8
thromboembolism vte
8
unresolved questions
4
questions venous
4
venous thromboembolic
4
thromboembolic disease
4
disease venous
4
vte management
4
management obese
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!